Key facts
- It has raised $10K; the latest was Early Stage VC in Mar 2026.
- Notable investors include Kunsen, Madrid Emprende, Successful Fund, madri+d Knowledge Foundation.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Synthetrial
- ·The full record, as it builds
Funding rounds
No funding rounds for Synthetrial are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Synthetrial
Developer of a generative artificial intelligence platform intended to support the optimization of clinical and healthcare trials through the use of synthetic patient data. The company's platform generates virtual patient datasets from small samples of real clinical data, applies predictive modeling to estimate future patient characteristics and trial outcomes, supports early forecasting of trial evolution, provides tools for statistical significance analysis, and incorporates validation methods trained on large volumes of clinical datasets across multiple therapeutic areas, enabling pharmaceutical companies, research organizations, and healthcare institutions to reduce trial duration and costs, identify high-risk or low-probability studies earlier, improve decision-making during trial design and execution, and enhance patient safety by limiting exposure to ineffective trials.
- Sector
- Healthcare
- HQ
- Madrid, Spain
- Founded
- 2024
- Employees
- 3
- Website
- synthetrial.com/
- Ownership
- Privately Held (backing)
Synthetrial doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Synthetrial shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Synthetrial in its N-PORT filings yet. We sweep new filings monthly.